Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation (EW) Stock Ticker

NYSE: EW · Healthcare · Medical - Devices
$86.83+0.65%
USD · as of 2026-09-29 · market cap $49.7B
Open EW in TickrRead the EW AI analysisDownload for iPhone

EW right now

Options expect by Oct 6±4.8%
Options expect by Oct 29±9.9%
Priced in for Oct 29 earnings±9.9%
IV rank (30-day)57% · fair
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full EW picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on EW
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

EW stock facts

Ticker symbolEW
ExchangeNew York Stock Exchange
SectorHealthcare
IndustryMedical - Devices
Market cap$49.7B
CEOBernard J. Zovighian
Employees16,000
HeadquartersIrvine, CA, US
IPO date2000-03-27
Websitewww.edwards.com

What you can see for EW on Tickr

Live EW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EW report.

Rankings

Largest Healthcare companiesLargest companies by market cap

EW peers

AALCARGXBDXBRKRCAHDXCMHLN

FAQ

What is the ticker symbol for Edwards Lifesciences Corporation?

The ticker symbol for Edwards Lifesciences Corporation is EW, listed on the New York Stock Exchange.

What is EW?

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease…

HomeExploreMarketLists
All pages